Home | A panel of predictive markers, a way to predict the occurrence of drug-resistant epilepsy in girls up to 24 months of age with tuberous sclerosis, and the use of a panel of markers in this method
Diagnostics
A panel of predictive markers, a way to predict the occurrence of drug-resistant epilepsy in girls up to 24 months of age with tuberous sclerosis, and the use of a panel of markers in this method
Patent inventors: Adria-Jaume Roura Canalda, Bartłomiej Gielniewski, Jacek Jaworski, Sergiusz Jóźwiak, Bożena Kamińska-Kaczmarek, Katarzyna Kotulska-Jóźwiak, Ewa Liszewska, Bartosz Wojtas
A panel of blood RNA markers for the prediction of epilepsy, in particular drug resistant epilepsy, in girls aged up to 24 months with tuberous sclerosis, characterised in that it comprises the following markers GLV1-40, IGVK4-1, IGLC7, IGLV3-19, IGHV4-34, IGKV1-39, IGHV6-1, IGHV1-3, IGHV3-53, IGKV3-15, TNFRSF13B, IGLJ2 (with addition of at least one marker: IGHV5-51, RRP7A, IGKV1-16, KTI12, HRAS).
Nencki Institute is the co-applicant with Medical University of Warsaw, International Institute of Molecular and Cell Biology in Warsaw, and Children's Memorial Health Institute in Warsaw. Medical University of Warsaw is the leader in patent protection and commercialization-related activities.
For more information contact Technology Transfer Office.
Application number:
P.440700 and EP22163334.0 (21.03.2022)
Patent status:
pending